Loteprednol Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

NCT01996839 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

514

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammation
Pain
Cataract

Interventions

DRUG: Loteprednol Etabonate Gel (BID)
DRUG: Loteprednol Etabonate Gel (TID)
DRUG: Vehicle (BID)
DRUG: Vehicle (TID)

Sponsor

Bausch & Lomb Incorporated